- Investing Ideas
- /
- Global Undervalued Stocks Based On Cash Flows
Global Undervalued Stocks Based On Cash Flows
Results
878
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
878 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
7220 | JP¥4,020.00 | 2.3% | 187.3% | JP¥263.4b | JP¥3,716.67 | PE36.1x | E25.5% | 1.2% | Automobiles | ||
601187 | CN¥5.68 | -1.7% | 12.9% | CN¥15.0b | n/a | PB0.5x | E26.4% | 5.3% | Banks | ||
605016 | CN¥16.64 | 0% | -28.6% | CN¥5.4b | CN¥22.75 | PE23x | E30.6% | 1.1% | Food, Beverage & Tobacco | ||
285 | HK$39.85 | -3.6% | 21.5% | HK$89.8b | HK$41.50 | PE20.8x | E24.0% | 1.4% | Tech | ||
GMR | UK£0.36 | -1.9% | 4.3% | UK£106.1m | UK£0.54 | PE15.8x | E22.1% | n/a | Media | ||
002917 | CN¥9.59 | -6.0% | 1.4% | CN¥3.3b | n/a | PE25.5x | E38.6% | 1.0% | Materials | ||
2172 | HK$9.18 | 2.3% | -24.1% | HK$5.3b | HK$12.22 | PE22.1x | E20.4% | 1.7% | Healthcare | ||
AGUAS-A | CL$291.30 | 0.8% | 5.2% | CL$1.7t | CL$342.60 | PE13.9x | E24.2% | 7.2% | Utilities | ||
522 | HK$75.95 | -3.4% | 0% | HK$31.5b | HK$104.85 | PE75.6x | E45.7% | 1.1% | Semiconductors | ||
TTR1 | €15.40 | -11.2% | -30.0% | €106.4m | €21.00 | PE14.2x | E23.1% | 4.0% | Capital Goods | ||
EQBK | US$46.66 | -1.3% | 40.8% | US$806.9m | US$52.40 | PB1.6x | E34.5% | 1.3% | Banks | ||
WETTERI | €0.30 | 2.4% | -40.7% | €47.8m | €0.40 | PS0.09x | E86.1% | n/a | Retail | ||
GALD | CHF 94.94 | 5.7% | n/a | CHF 22.6b | CHF 99.17 | PS5.8x | E44.6% | n/a | Pharmaceuticals & Biotech | ||
ALE | zł28.46 | -6.1% | -15.5% | zł30.1b | zł38.22 | PE54.8x | E27.6% | n/a | Retail | ||
UMBF | US$123.38 | -0.2% | 48.9% | US$6.0b | US$138.33 | PB1.7x | E35.5% | 1.3% | Banks | ||
BFST | US$27.78 | -1.5% | 17.1% | US$823.3m | US$33.25 | PB1.3x | E21.7% | 2.0% | Banks | ||
CSTM | US$11.01 | -7.2% | -42.8% | US$1.6b | US$18.00 | PE15.5x | E52.9% | n/a | Materials | ||
BVC | UK£0.19 | -1.3% | -12.5% | UK£81.0m | n/a | PS0.8x | E90.4% | n/a | Tech | ||
SKS | AU$1.95 | -2.0% | 634.0% | AU$218.0m | AU$2.15 | PE32.9x | E24.8% | 0.5% | Capital Goods | ||
PRVA | US$21.87 | 1.7% | -4.2% | US$2.5b | US$26.19 | PE204.6x | E39.0% | n/a | Healthcare | ||
506655 | ₹1,135.25 | 0.2% | 116.9% | ₹78.6b | ₹1,062.78 | PE59.6x | E33.2% | 0.4% | Materials | ||
GTRONIC | RM 0.59 | 3.5% | -63.7% | RM 401.9m | RM 0.85 | PE35.5x | E31.8% | 5.9% | Semiconductors | ||
BRCK | UK£0.64 | -1.5% | 24.2% | UK£204.0m | UK£0.97 | PE24.6x | E46.5% | 5.3% | Capital Goods | ||
688526 | CN¥14.77 | -5.6% | -19.2% | CN¥6.9b | CN¥20.20 | PE22.9x | E24.3% | 2.9% | Pharmaceuticals & Biotech |